secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clovis Oncology, Inc. (—)
CIK:        0001466301
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001193125-22-303183
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Clovis Oncology to be delisted from Nasdaq on Dec 21 after Chapter 11 filing; shares to trade OTC under CLVSQ
--------------------------------------------------------------------------------

- Received delisting notice from Nasdaq on Dec 12, 2022 due to Chapter 11 bankruptcy petitions filed Dec 11.
- Trading suspension effective at open on Dec 21; company will not appeal the determination.
- Common stock expected to trade OTC beginning Dec 21 under symbol CLVSQ.
- Nasdaq cited inability to sustain compliance and public interest concerns as grounds for delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1466301/000119312522303183/0001193125-22-303183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1466301/000119312522303183/d425649d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-303183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer